Summit Therapeutics Inc. Common Stock (SMMT) Stock Price, Quote & AI Analysis

Live SMMT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Summit Therapeutics Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Summit Therapeutics Inc. Common Stock (SMMT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

SMMT
Summit Therapeutics Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$11,643,081,294.32
52W Range
$14.20 - $36.91
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 23, 2026 Q4
Before Open
EPS Estimate: $-0.0656
Revenue Estimate: $102,000,000.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Summit Therapeutics Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Summit Therapeutics Inc. Common Stock Overview

Company information

Company Overview

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Company Details
Market Cap
$10.58B
Shares Outstanding
744,443,000
Weighted Shares Outstanding
744,442,538
CEO
Robert William Duggan
Address
601 BRICKELL KEY DRIVE, MIAMI, FL, 33131
Employees
159
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Summit Therapeutics Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...